COMPANY

Emmune Inc.

HQ: Juno Beach, FL source · emmune.bio ↗ · New England

Emmune develops eCD4-Ig as a recombinant protein therapeutic for HIV infection and as an AAV-expressed one-time intervention for treatment and prevention of HIV infection. Emmune aims to apply its AAV vector platform to other diseases. From company website Source · checked 2026-10-19

EMMUNE INC has received NIH funding, most recently in fiscal 2026 for the project “PK, tolerability, and toxicology studies for eCD4-Ig as a long-acting recombinant protein therapeutic”. From public records Source · 2026-10-12

Sources for this description (2)

Emmune develops eCD4-Ig as a recombinant protein therapeutic for HIV infection and as an AAV-expressed one-time intervention for treatment and prevention of HIV infection.
- “Emmune was founded to develop eCD4-Ig as a recombinant protein therapeutic for treating HIV infection, and to develop AAV-expressed eCD4-Ig as a one-time therapeutic intervention for life-long treatment and prevention of HIV infection.” https://emmune.bio/mission-statement/ (2026-10-19)
Emmune aims to apply its AAV vector platform to other diseases.
- “Emmune seeks the broad application of its innovations on the AAV vector platform to other diseases.” https://emmune.bio/mission-statement/ (2026-10-19)

Disease: hiv infection

Keywords:

Location: Cambridge, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $300K (SBIR Phase II 1R44HL184837-01A1, new, notice Aug 24, 2026); 2 NIH awards totaling $599K in the last 12 months. NIH RePORTER 1R44HL184837-01A1 (Aug 24, 2026)
Evidence (2 events)
- Aug 24, 2026 · NIH RePORTER 1R44HL184837-01A1
  Organization: EMMUNE, INC; City/State: Juno Beach, FL; Project number: 1R44HL184837-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-24; FY total cost (award amount): 299664; Administering IC: National Heart Lung and Blood Institute; Project title: Non-viral gene therapy to treat and prevent atherosclerosis; Organization type: Domestic For-Profits
- Jul 24, 2026 · NIH RePORTER 1R44AI197364-01
  Organization: EMMUNE, INC; City/State: Juno Beach, FL; Project number: 1R44AI197364-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-24; FY total cost (award amount): 299352; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: PK, tolerability, and toxicology studies for eCD4-Ig as a long-acting recombinant protein therapeutic; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Aug 24, 2026 Grant Government grant — SBIR: $299,664 (annual award, as published), announced Aug 24, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 24, 2026 Grant Government grant — SBIR: $299,352 (annual award, as published), announced Jul 24, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 23, 2025 Grant Government grant — SBIR: $999,997 (annual award, as published), announced Sep 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 5, 2025 Grant Government grant — SBIR: $1M (annual award, as published), announced Aug 5, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 17, 2025 Grant Government grant — NIH R56: $917,294 (annual award, as published), announced Jun 17, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
May 9, 2025 Grant Government grant — SBIR: $300,000 (annual award, as published), announced May 9, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Aug 24, 2026 Government grant — SBIR: $299,664 (annual award, as published), announced Aug 24, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 24, 2026 Government grant — SBIR: $299,352 (annual award, as published), announced Jul 24, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 23, 2025 Government grant — SBIR: $999,997 (annual award, as published), announced Sep 23, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 5, 2025 Government grant — SBIR: $1M (annual award, as published), announced Aug 5, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 17, 2025 Government grant — NIH R56: $917,294 (annual award, as published), announced Jun 17, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
May 9, 2025 Government grant — SBIR: $300,000 (annual award, as published), announced May 9, 2025. Agency: NIH/NIAID. Source: government award database. source ↗